First Western Trust Bank Sells 47 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

First Western Trust Bank cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,282 shares of the healthcare conglomerate’s stock after selling 47 shares during the period. First Western Trust Bank’s holdings in UnitedHealth Group were worth $750,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in UNH. Mendel Capital Management LLC lifted its stake in shares of UnitedHealth Group by 3.0% in the 3rd quarter. Mendel Capital Management LLC now owns 1,149 shares of the healthcare conglomerate’s stock valued at $672,000 after purchasing an additional 33 shares during the last quarter. Aviso Wealth Management lifted its position in UnitedHealth Group by 6.5% in the third quarter. Aviso Wealth Management now owns 834 shares of the healthcare conglomerate’s stock worth $488,000 after buying an additional 51 shares during the last quarter. Braun Stacey Associates Inc. raised its stake in shares of UnitedHealth Group by 6.0% in the third quarter. Braun Stacey Associates Inc. now owns 45,941 shares of the healthcare conglomerate’s stock valued at $26,861,000 after acquiring an additional 2,599 shares during the period. GLOBALT Investments LLC GA boosted its stake in shares of UnitedHealth Group by 112.1% during the 3rd quarter. GLOBALT Investments LLC GA now owns 12,903 shares of the healthcare conglomerate’s stock worth $7,544,000 after purchasing an additional 6,819 shares during the period. Finally, AMG National Trust Bank raised its position in UnitedHealth Group by 4.6% in the 3rd quarter. AMG National Trust Bank now owns 17,673 shares of the healthcare conglomerate’s stock worth $10,333,000 after purchasing an additional 778 shares during the period. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on UNH. TD Cowen increased their price target on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Cantor Fitzgerald lifted their target price on UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 16th. Bank of America reduced their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. KeyCorp began coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 target price on the stock. Finally, UBS Group lowered their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Trading Down 0.2 %

NYSE UNH opened at $592.23 on Monday. The company has a 50 day moving average price of $582.84 and a 200 day moving average price of $549.98. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The firm has a market cap of $545.02 billion, a PE ratio of 38.58, a price-to-earnings-growth ratio of 1.74 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period in the previous year, the business earned $6.56 EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be paid a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. UnitedHealth Group’s payout ratio is 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.